aTyr Pharma
Yeeting (Esther) Chong has a strong background in scientific research and experience in various roles. Yeeting (Esther) worked as a Scientist at aTyr Pharma from October 2012 to the present. Prior to that, they held positions at The Scripps Research Institute, where they were a Post-doctoral research associate from February 2011 to October 2012, and a Graduate student from August 2005 to January 2011. Yeeting (Esther) also gained research experience as a Research Intern at Merck in May 2004.
Yeeting (Esther) Chong has an extensive education history in the field of biochemistry. Yeeting (Esther) first pursued their Bachelor of Arts degree in Biological Sciences and Chemistry at Cornell University from 2001 to 2005. Following this, they briefly studied Biochemistry at the University of Canterbury in 2001. This was followed by their pursuit of a PhD in Biochemistry at Scripps Research for a duration of six years, from 2005 to 2011.
aTyr Pharma
aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways.